News from NORD

NCATS Unveils Toolkit for Patient-Focused Therapy Development

Publish date: August 7, 2018

 

The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) has developed a new toolkit for the rare disease community to facilitate therapeutics research and development. Learn more about the toolkit here.

Recommended Reading

How Accurately Do Current Criteria Identify CBD and PSP?
MDedge Neurology
Risk of ALS May Increase With Greater Exposure to Diesel Exhaust
MDedge Neurology
Childhood Neuromuscular Disease as a Metaphor for the Scientific Advances in Child Neurology of the Last Quarter Century
MDedge Neurology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Neurology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Neurology
RFPs Available for the Study of Three Rare Diseases
MDedge Neurology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Neurology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Neurology
NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans
MDedge Neurology
Running for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed Patients
MDedge Neurology